IL6 and osteoporosis: IL-6 acts as a critical marker of inflammation as well as a feature of aging and plays a role in the pathophysiological mechanisms driving age-related diseases (e.g., osteoporosis, heart failure, AD, the decline in cognitive performance, and community-acquired pneumonia requiring hospitalization) (34–38).